Vacuum technology enables optimum cooling of Corona vaccines
(firmenpresse) - The first approvals for Corona vaccines were granted late last year. Worldwide, vaccination of people against the virus began. Currently, 552 million people all over the world have already been vaccinated (source: www.ourworldindata.org, figures as of March 28, 2021). Vacuum technology is also needed to produce and transport the vaccines. Cooling the vaccines, for example, plays an essential role in global distribution. A customer of Busch Vacuum Solutions manufactures special vaccine refrigerators and temperature-controlled transport boxes for vaccines. And is thus making an important contribution to the global fight against the pandemic.
In contrast to conventional vaccines, the logistics of Corona vaccines present a whole new challenge. The first approved vaccine comes from the German pharmaceutical company BioNTech and its American partner company Pfizer. To cool this vaccine, conventional refrigerators, such as those used for flu vaccines, are not sufficient. The Corona vaccine must be stored and transported at minus 70 degrees Celsius. So that it retains its full effectiveness.
In building the special refrigeration units, the Belgian company relies entirely on vacuum technology from Busch Vacuum Solutions. Vacuum is used to fill the cooling circuits of the refrigeration units with special gases. Due to the worldwide pandemic, the demand for these cooling units has risen sharply in recent months, and Busch was able to meet the expanded requirements by supplying additional vacuum pumps. These cooling units and transport equipment are sold worldwide and are used in the distribution of the vaccine around the globe. An essential product to ensure that the COVID-19 vaccine reaches vaccination centers intact and patients worldwide can receive the much-needed vaccination.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Busch Vacuum Solutions is one of the world’s largest producers of vacuum pumps, vacuum systems, blowers and compressors.
Its extensive product portfolio comprises solutions for vacuum and overpressure applications in all industries, including the chemical, semiconductor, medical technology, plastics, and food sectors. It also covers the design and construction of customized vacuum systems, as well as a global service network.
The Busch group is a family-owned company and is still managed by the Busch family. Busch Vacuum Solutions has 3,500 employees in more than 60 companies in over 40 countries worldwide. Busch is headquartered in Maulburg, in southwest Germany. This is the location of Busch SE headquarters, as well as the German production facility and German sales company. In addition to Maulburg, Busch also has its own production plants in Switzerland, the UK, Czech Republic, Korea and the USA.
Jasmin Markanic
Coordinator Global Press & Media Relations
+49 (0) 7622 681-3376
Jasmin.markanic(at)busch.de
Busch Vacuum Solutions
Schauinslandstraße 1
79689 Maulburg, Germany
www.buschvacuum.com
Datum: 01.04.2021 - 03:43 Uhr
Sprache: Deutsch
News-ID 1566207
Anzahl Zeichen: 1823
contact information:
Contact person: Jasmin Markanic
Town:
Maulburg
Phone: +49 (0) 7622 681-3376
Kategorie:
Manufacturing & Production
Typ of Press Release: Success
type of sending: send
Date of sending: 01.04.2021
Anmerkungen:
Diese Pressemitteilung wurde bisher 553 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Vacuum technology enables optimum cooling of Corona vaccines
"
steht unter der journalistisch-redaktionellen Verantwortung von
Busch Vacuum Solutions (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
